By using this site, you agree to the Privacy Policy and Terms of Use.
Accept
Medical Information, Documents, News - TheMediTary.Com Logo Medical Information, Documents, News - TheMediTary.Com Logo

TheMediTary.Com

Medical Information, Documents, News - TheMediTary.Com

  • Home
  • News
  • Drugs
  • Drugs A-Z
  • Medical Answers
  • About Us
  • Contact
Medical Information, Documents, News - TheMediTary.Com Logo Medical Information, Documents, News - TheMediTary.Com Logo
Search Drugs
  • Drugs
    • Latest Drugs
    • Drugs A-Z
    • Medical Answers
  • News
    • FDA Alerts
    • Medical News
    • Health
    • Consumer Updates
    • Children's Health
  • More TheMediTary.Com
    • About Us
    • Contact
Follow US
Home > Drugs > Bronchodilator combinations > Budesonide, formoterol, and glycopyrrolate > Budesonide / Formoterol / Glycopyrrolate Dosage
Bronchodilator combinations
https://themeditary.com/dosage-information/budesonide-formoterol-glycopyrrolate-dosage-10863.html

Budesonide / Formoterol / Glycopyrrolate Dosage

Drug Detail:Budesonide, formoterol, and glycopyrrolate (Budesonide, formoterol, and glycopyrrolate [ bue-des-oh-nide, for-moe-te-rol, and-glye-koe-pir-oh-late ])

Drug Class: Bronchodilator combinations

Contents
Uses Warnings Before Taking Dosage Side effects Interactions

Usual Adult Dose for Chronic Obstructive Pulmonary Disease - Maintenance

2 oral inhalations twice a day (morning and evening)
Maximum dose: 2 inhalations twice a day

Comments:

  • Limitations of Use: This drug is not indicated for the relief of acute bronchospasm or for the treatment of asthma.
  • Each inhalation contains budesonide 160 mcg, formoterol fumarate 4.8 mcg, and glycopyrrolate 9 mcg.

Use: For the maintenance treatment of patients with COPD

Renal Dose Adjustments

Severe renal dysfunction (CrCl up to 30 mL/min/1.73 m2): Data not available

Comments:

  • Formal pharmacokinetic (PK) studies have not been performed in patients with renal dysfunction.
  • This drug should only be used in patients with severe renal dysfunction if the expected benefit outweighs the potential risk.

Liver Dose Adjustments

Severe liver dysfunction: Close monitoring recommended.

Comments:

  • Formal PK studies have not been performed in patients with liver dysfunction.
  • Budesonide and formoterol fumarate are primarily cleared by hepatic metabolism, so liver dysfunction may lead to accumulation of these drugs in plasma.

Precautions

CONTRAINDICATIONS:
Demonstrated hypersensitivity to an active component or to any of the ingredients

Safety and efficacy have not been established in patients younger than 18 years.

Consult WARNINGS section for additional precautions.

Dialysis

ESRD requiring dialysis: Data not available

Comments:

  • Formal PK studies have not been performed in patients with renal dysfunction.
  • This drug should only be used in patients with ESRD requiring dialysis if the expected benefit outweighs the potential risk.

Other Comments

Administration advice:

  • Shake well before each spray.
  • Prime inhaler before first use by releasing 4 sprays into the air away from face; if not used for more than 7 days, if dropped, or after weekly cleaning, prime inhaler again by releasing 2 sprays into the air away from face.
  • After inhalation, rinse mouth with water without swallowing.
  • Only use the canister of this drug with the provided actuator; do not use this actuator with any other inhalation drug product.
  • Do not use near heat or open flames; avoid spraying in eyes.
  • Discard when the dose indicator display window shows zero OR 3 months (120-inhalation canister) or 3 weeks (28-inhalation canister) after removal from foil pouch, whichever comes first; never immerse canister into water to determine amount remaining in canister ("float test").

Storage requirements:
  • Store at 20C to 25C (68F to 77F); excursions permitted to 15C to 30C (59F to 86F).
  • Keep in dry place away from heat and sunlight.
  • Do not store near heat or open flames; bursting may occur if exposed to temperatures above 49C (120F).

General:
  • No dosage adjustment is needed for elderly patients.
  • Contents are under pressure; the canister should not be punctured and should never be thrown into fire or incinerator.

Monitoring:
  • Endocrine: For inadequate adrenal response (postoperatively or during periods of stress)
  • General: For systemic corticosteroid effects
  • Genitourinary: For signs/symptoms of prostatic hyperplasia or bladder-neck obstruction
  • Infections/Infestations: For pneumonia
  • Musculoskeletal: Bone mineral density (before starting therapy and periodically thereafter)
  • Ocular: For signs/symptoms of acute narrow-angle glaucoma

Patient advice:
  • Read the US FDA-approved patient labeling (Patient Information and Instructions for Use).
Share this Article
Latest News
Medical News

Shingles vaccine may lower heart disease risk by up to 8 years

May 09, 2025
Obesity, unhealthy lifestyles may cause heart to age by 5–45 years
Aging: As little as 5 minutes of exercise may keep the brain healthy
Prostate cancer: Simple urine test may help with early detection
Cancer treatment side effects: Exercise may reduce pain, fatigue
Alzheimer's: Exercising in middle age may reduce beta-amyloid in brain...
Related Drugs
Fidanacogene Elaparvovec
Cerave Anti-Itch
Centrum Adult
Crovalimab
Cyltezo Prefilled Syringe
Zepbound Pen
Mylanta One
Uretron Ds
Medihoney Wound And Burn Dressing
Lidotrode

Other drugs

Name Drug Class Updated
Fidanacogene Elaparvovec Drugs 03-Oct-2024
Cerave Anti-Itch Drugs 02-Oct-2024
Centrum Adult Drugs 02-Oct-2024
Crovalimab Drugs 02-Oct-2024
Cyltezo Prefilled Syringe Drugs 01-Oct-2024
Zepbound Pen Drugs 30-Sep-2024
Mylanta One Drugs 27-Sep-2024
Uretron Ds Drugs 27-Sep-2024
Medihoney Wound And Burn Dressing Drugs 26-Sep-2024
Lidotrode Drugs 26-Sep-2024
Libervant Drugs 26-Sep-2024
Moderna Covid-19 Drugs 25-Sep-2024
Beqvez Drugs 24-Sep-2024
Beqvez Drugs 24-Sep-2024
Beqvez Drugs 24-Sep-2024

Categories

  • FDA Alerts
  • Medical News
  • Health
  • Consumer Updates
  • Children's Health

About US

Welcome to TheMediTary.Com

Our website provides reliable and up-to-date information on various medical topics. We empower individuals to take charge of their health by simplifying complex medical jargon and providing practical tips and advice. We prioritize the privacy and confidentiality of our users and welcome feedback to improve our services.

Website use data of FDA and other sources

DMCA.com Protection Status Truste Protection Status Trust Mark Protection Status
HONcode logo We comply with the HONcode standard for trustworthy health information.
Quick Link
  • About Us
  • Contact Us
  • Editorial Policy
  • Privacy Policy
  • Accessibility Policy
  • Terms & Conditions
  • Disclaimer
  • DMCA
  • Do Not Sell My Personal Information
  • Sitemap
  • Care Notes
  • Health Guide
  • Professional
Drugs
  • New Drugs
  • Medical Answers
  • Drugs A-Z
  • Drug Classes
  • Drug Dosage
  • Pill Identifier
  • Consumer Infor
  • Side Effects
  • Inactive Ingredients
  • Pregnancy Warnings
  • Patient Tips
  • Treatments
News
  • Latest News
  • FDA Alerts
  • Medical News
  • Health
  • Consumer Updates
  • Children's Health
Find US
  • Medium
  • Google Site
  • Blogspot
  • API
  • Reddit
  • Tumblr
  • Scoop.it
  • Substack
  • Wordpress
  • Wix
  • Behance

© 2025 TheMediTary.Com All rights reserved. Operated by